Telo Genomics Financials
| TDSGF Stock | USD 0.09 0.02 34.29% |
With this module, you can analyze Telo financials for your investing period. You should be able to track the changes in Telo Genomics individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Telo |
Understanding current and past Telo Genomics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Telo Genomics' financial statements are interrelated, with each one affecting the others. For example, an increase in Telo Genomics' assets may result in an increase in income on the income statement.
The data published in Telo Genomics' official financial statements typically reflect Telo Genomics' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Telo Genomics' quantitative information. For example, before you start analyzing numbers published by Telo accountants, it's essential to understand Telo Genomics' liquidity, profitability, and earnings quality within the context of the Health Care Technology space in which it operates.
Telo Genomics Stock Summary
Telo Genomics competes with EXACT Sciences, Natera, Caredx, Illumina, and Twist Bioscience. Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada. TELO GENOMICS is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | CA87975M2085 |
| Business Address | MaRS Centre, Toronto, |
| Sector | Health Care Technology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.telodx.com |
| Phone | 416 673 8487 |
| Currency | USD - US Dollar |
Telo Genomics Key Financial Ratios
There are many critical financial ratios that Telo Genomics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Telo Genomics Corp reports annually and quarterly.Telo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Telo Genomics's current stock value. Our valuation model uses many indicators to compare Telo Genomics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Telo Genomics competition to find correlations between indicators driving Telo Genomics's intrinsic value. More Info.Telo Genomics Corp is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Telo Genomics' earnings, one of the primary drivers of an investment's value.Telo Genomics Corp Systematic Risk
Telo Genomics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Telo Genomics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Telo Genomics Corp correlated with the market. If Beta is less than 0 Telo Genomics generally moves in the opposite direction as compared to the market. If Telo Genomics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Telo Genomics Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Telo Genomics is generally in the same direction as the market. If Beta > 1 Telo Genomics moves generally in the same direction as, but more than the movement of the benchmark.
Telo Genomics November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Telo Genomics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Telo Genomics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Telo Genomics Corp based on widely used predictive technical indicators. In general, we focus on analyzing Telo OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Telo Genomics's daily price indicators and compare them against related drivers.
| Downside Deviation | 16.82 | |||
| Information Ratio | 0.0033 | |||
| Maximum Drawdown | 76.69 | |||
| Value At Risk | (19.77) | |||
| Potential Upside | 30.0 |
Complementary Tools for Telo OTC Stock analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |